Drug
Rc28 E
Rc28 E: highest development phase Phase 3, developed by RemeGen Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- RemeGen Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| RC28-E NCT07936487 | Phase 3 | Diabetic Macular Edema (DME) |
Latest
No recent events.
Follow Rc28 E on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.